0001779372-23-000017.txt : 20230609 0001779372-23-000017.hdr.sgml : 20230609 20230609195912 ACCESSION NUMBER: 0001779372-23-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230514 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Persen Kenneth Harry CENTRAL INDEX KEY: 0001942350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41060 FILM NUMBER: 231006826 MAIL ADDRESS: STREET 1: 2118 WALSH AVENUE, SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HeartBeam, Inc. CENTRAL INDEX KEY: 0001779372 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 474881450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2118 WALSH AVE., SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 BUSINESS PHONE: 408-899-4443 MAIL ADDRESS: STREET 1: 2118 WALSH AVE., SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 4 1 wk-form4_1686355142.xml FORM 4 X0407 4 2023-05-14 0 0001779372 HeartBeam, Inc. BEAT 0001942350 Persen Kenneth Harry 2118 WALSH AVENUE, SUITE 210 SANTA CLARA CA 95050 0 1 0 0 Chief Technology Officer 0 Stock option (right to buy) 2023-05-14 4 A 0 169000 0 A 2033-05-13 Common Stock 169000 169000 D The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as of May 14, 2023. The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023. The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals. /s/ Kenneth Persen 2023-06-09